Long-term risk of gynecologic malignancies in postmenopausal women with vaginal bleeding and benign endometrial lesions: a cohort study - Report - MDSpire

Long-term incidence of gynecologic cancers in postmenopausal women experiencing vaginal bleeding with benign endometrial findings: a cohort analysis

  • By

  • Chunxiu Lv

  • Mingrui Su

  • Xiaojuan Zheng

  • Jinfeng Li

  • Lei Zhu

  • Shuzhen Wang

  • Jianxin Zhang

  • July 20, 2026

Share

Clinical Report: Long-term incidence of gynecologic cancers in postmenopausal women

Overview

This study evaluates the long-term risk of gynecologic malignancy in postmenopausal women with vaginal bleeding and benign endometrial findings. It identifies independent risk factors for malignancy, emphasizing the need for ongoing surveillance in this population.

Background

Postmenopausal vaginal bleeding is a common clinical issue that can signal underlying malignancies, particularly endometrial cancer. Despite the majority of cases being benign, the potential for undetected malignancies necessitates thorough evaluation and follow-up. Understanding the long-term risks associated with benign findings is crucial for improving patient outcomes.

Data Highlights

ParameterValue
Initial malignancy diagnosis rate15.1% (105/696)
Initial precancerous lesions diagnosis rate2.9% (20/696)
Malignancy diagnosed within 3 months of benign pathology5.1% (6/118)
Precancerous lesions diagnosed within 3 months7.6% (9/118)
Incident malignancies during follow-up16
Incident precancerous lesions during follow-up8
High-grade serous carcinoma proportion during follow-up43.8%

Key Findings

  • 15.1% of postmenopausal women with vaginal bleeding had endometrial malignancy at initial diagnosis.
  • 5.1% of patients with initially benign pathology were diagnosed with malignancy within 3 months.
  • High-grade serous carcinoma was significantly more common in follow-up diagnoses compared to initial diagnoses (43.8% vs. 6.5%).
  • Baseline red blood cell distribution width (RDW) and endometrial thickness were identified as independent predictors of gynecologic malignancy.
  • 25.4% of patients were lost to follow-up during the study.

Clinical Implications

The findings highlight the importance of long-term follow-up for postmenopausal women with benign endometrial lesions, as they may still be at risk for developing malignancies. Clinicians should consider standardized screening protocols to monitor this high-risk group effectively.

Conclusion

Postmenopausal women with vaginal bleeding and benign endometrial findings are at an elevated risk for gynecologic malignancies, necessitating vigilant long-term surveillance.

Related Resources & Content

  1. ACOG, ACOG, 2026 -- ACOG Publishes Updated Guidance on Evaluation of Postmenopausal Bleeding
  2. Angela Nolin, MD, ASCO Post, 2025 -- Study Shows Disparities in Diagnosing Endometrial Cancer in Women With Postmenopausal Bleeding
  3. Frontiers in Endocrinology, 2026 -- Increased risk of postpartum hemorrhage in women with endometriosis and adenomyosis: a prospective cohort study
  4. ScienceDirect, 2025 -- Risk of endometrial cancer after insufficient endometrial biopsy: a retrospective cohort study
  5. the asco post — Study Shows Disparities in Diagnosing Endometrial Cancer in Women With Postmenopausal Bleeding
  6. the asco post — Short-Term Vaginal Estrogen Therapy Does Not Increase Risks of Endometrial Cancer Recurrence
  7. ACOG Publishes Updated Guidance on Evaluation of Postmenopausal Bleeding | ACOG
  8. Risk of endometrial cancer after insufficient endometrial biopsy: a retrospective cohort study - ScienceDirect

Original Source(s)

Related Content